TAKEDA PHARMA. 18/26 REGSTAKEDA PHARMA. 18/26 REGSTAKEDA PHARMA. 18/26 REGS

TAKEDA PHARMA. 18/26 REGS

No trades
See on Supercharts

XS184344912 analysis



Key facts


Issue date
Nov 21, 2018
Maturity date
Nov 21, 2026
Outstanding amount
‪1.50 B‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
2.25% (Fixed)
Yield to maturity
2.67%
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.